Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1143719

	registered interest
	date	02/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans the Government has to maintain medical and drug supplies to the UK in the event that the UK leaves the EU without a deal.
	tabling member constituency	Lanark and Hamilton East
	tabling member printed	Angela Crawley
	uin	285347
	answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>As part of a responsible Government, the Department is doing everything appropriate to prepare for European Union exit. We want to reassure patients that our plans should ensure the supply of medicines and medical products remains uninterrupted when we leave the EU on 31 October.</p><p>The Department is implementing a multi-layered approach, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages.</p> answering member constituency Kingswood answering member printed Chris Skidmore question first answered 09/09/2019 19:00:53 answering member 4021 label Biography information for Chris Skidmore
	tabling member	4469 label Biography information for Angela Crawley

1142693

	registered interest
	date	02/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect on treatments within NHS England’s Clinical Commissioning Policy programme of the closure of the Commissioning Support Programme; and if he will make a statement.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	284182
	answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>Further to the answer the Minister of State for Care (Caroline Dinenage MP) gave on 2 April 2019 to Question 236381, that NHS England has considered this issue, and does not believe that a gap has been created as a result of the closure of Commissioning Support Programme for treatments that are awaiting review by the Clinical Priorities Advisory Group.</p><p>The topics that would have been referred to the Commissioning Support Programme will now be routed to the appropriate appraisal programme.</p><p>All policy propositions relating to topics previously being supported in development through the Commissioning Support Programme have been handed over at the agreed stage for post stakeholder testing. These are now being progressed though the usual development process. Further information is available at the following link:</p><p><a href="https://www.england.nhs.uk/publication/methods-national-clinical-policies/" target="_blank">https://www.england.nhs.uk/publication/methods-national-clinical-policies/</a></p><p> </p><p> </p><p> </p> answering member constituency Kingswood answering member printed Chris Skidmore grouped question UIN 284181 question first answered 09/09/2019 18:52:46 answering member 4021 label Biography information for Chris Skidmore
	tabling member	4131 label Biography information for Jim Shannon

1142692

	registered interest
	date	02/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 2 April 2019 to Question 236381, what steps NHS England has taken to fill the gap left by the closure of the Commissioning Support Programme for treatments that are awaiting review by the Clinical Priorities Advisory Group.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	284181
	answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>Further to the answer the Minister of State for Care (Caroline Dinenage MP) gave on 2 April 2019 to Question 236381, that NHS England has considered this issue, and does not believe that a gap has been created as a result of the closure of Commissioning Support Programme for treatments that are awaiting review by the Clinical Priorities Advisory Group.</p><p>The topics that would have been referred to the Commissioning Support Programme will now be routed to the appropriate appraisal programme.</p><p>All policy propositions relating to topics previously being supported in development through the Commissioning Support Programme have been handed over at the agreed stage for post stakeholder testing. These are now being progressed though the usual development process. Further information is available at the following link:</p><p><a href="https://www.england.nhs.uk/publication/methods-national-clinical-policies/" target="_blank">https://www.england.nhs.uk/publication/methods-national-clinical-policies/</a></p><p> </p><p> </p><p> </p> answering member constituency Kingswood answering member printed Chris Skidmore grouped question UIN 284182 question first answered 09/09/2019 18:52:46 answering member 4021 label Biography information for Chris Skidmore
	tabling member	4131 label Biography information for Jim Shannon

1142749

	registered interest
	date	02/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the budget is for products undergoing review via the NHS England prioritisation process in 2020-21.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	284324
	answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>NHS England has not yet been set the budget for products undergoing review via the NHS England prioritisation process in 2020-21.</p> answering member constituency Kingswood answering member printed Chris Skidmore question first answered 09/09/2019 18:37:16 answering member 4021 label Biography information for Chris Skidmore
	tabling member	4131 label Biography information for Jim Shannon

1142688

	registered interest
	date	02/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to make the stabilisation of conditions such as cystic fibrosis part of the NICE quality of life measurement system and not just extension of life.
	tabling member constituency	Bermondsey and Old Southwark
	tabling member printed	Neil Coyle
	uin	284175
	answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 09/09/2019 17:27:04 answering member 4380 label Biography information for Jo Churchill
	tabling member	4368 label Biography information for Neil Coyle

1144589

	registered interest
	date	04/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department has undertaken a public consultation on the effectiveness of the NHS prioritisation process.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	286740
	answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 09/09/2019 16:35:45 answering member 4380 label Biography information for Jo Churchill
	tabling member	4131 label Biography information for Jim Shannon

1143648

	registered interest
	date	02/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential effect on the supply chains for medicines and medical supplies of the UK leaving the EU without a deal; what steps he is taking to protect ongoing supplies of medicines and medical supplies; and if he will update the dear colleague letter of the 27 June 2019 entitled No deal Brexit contingency planning assumptions for continuity of supply of medicines and medical products.
	tabling member constituency	Eddisbury
	tabling member printed	Antoinette Sandbach
	uin	285138
	answer	answer is ministerial correction date of answer 05/09/2019 answer text <p>As part of a responsible Government, the Department is doing everything appropriate to prepare for European Union exit. We want to reassure patients that we should be fully prepared for leaving on 31 October, and that our plans should ensure the supply of medicines and medical products remains uninterrupted when we leave the EU.</p><p>The Department is implementing a multi-layered approach, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. This should ensure the continuity of supply of medicines and medical products following EU exit.</p><p>We continue to engage with stakeholders and update our communications regularly. We are looking to update Members shortly.</p> answering member constituency Kingswood answering member printed Chris Skidmore question first answered 05/09/2019 16:37:54 answering member 4021 label Biography information for Chris Skidmore
	tabling member	4506 label Biography information for Antoinette Sandbach

1139370

	registered interest
	date	16/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect of the closure of the Commissioning Support Programme on treatments within NHS England’s Clinical Commissioning Policy programme; and if he will make a statement.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	277725
	answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>NHS England does not believe that the closure of the Commissioning Support Programme will leave a gap in the review of treatments.</p><p>The topics that would have been referred to the Commissioning Support Programme will now be routed to the appropriate appraisal programme, undertaken by the National Institute for Health and Care Excellence (NICE), except where there is a clear rationale not to do so. NICE expects to implement this expansion from April 2020. It will be in a position to start progressing topics through the NICE topic selection process from the summer of 2019.</p><p>All policy propositions relating to topics previously being supported in development through the Commissioning Support Programme have been handed over at the agreed stage as for all topics, post stakeholder testing. These are now being progressed though the usual development process. This process is set out in ‘Methods: National Clinical Policies’ at the following link:</p><p><a href="https://www.england.nhs.uk/publication/methods-national-clinical-policies/" target="_blank">https://www.england.nhs.uk/publication/methods-national-clinical-policies/</a></p><p>The voluntary scheme agreed between Department and the Association of the British Pharmaceutical Industry on getting the best value and most effective medicines into use more quickly for branded medicines pricing and access was published in November 2018. The voluntary scheme started on 1 January 2019 and will be in place for five years until 2023.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 277724 question first answered 23/07/2019 16:50:58 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4131 label Biography information for Jim Shannon

1139369

	registered interest
	date	16/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 2 April 2019 to Question 236381, what steps NHS England has taken to fill the gap left by the closure of the Commissioning Support Programme for those treatments that are awaiting review by the Clinical Priorities Advisory Group.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	277724
	answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>NHS England does not believe that the closure of the Commissioning Support Programme will leave a gap in the review of treatments.</p><p>The topics that would have been referred to the Commissioning Support Programme will now be routed to the appropriate appraisal programme, undertaken by the National Institute for Health and Care Excellence (NICE), except where there is a clear rationale not to do so. NICE expects to implement this expansion from April 2020. It will be in a position to start progressing topics through the NICE topic selection process from the summer of 2019.</p><p>All policy propositions relating to topics previously being supported in development through the Commissioning Support Programme have been handed over at the agreed stage as for all topics, post stakeholder testing. These are now being progressed though the usual development process. This process is set out in ‘Methods: National Clinical Policies’ at the following link:</p><p><a href="https://www.england.nhs.uk/publication/methods-national-clinical-policies/" target="_blank">https://www.england.nhs.uk/publication/methods-national-clinical-policies/</a></p><p>The voluntary scheme agreed between Department and the Association of the British Pharmaceutical Industry on getting the best value and most effective medicines into use more quickly for branded medicines pricing and access was published in November 2018. The voluntary scheme started on 1 January 2019 and will be in place for five years until 2023.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 277725 question first answered 23/07/2019 16:50:58 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4131 label Biography information for Jim Shannon

1139933

	registered interest
	date	17/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether NICE’s multiple technology appraisal process can be applied to treatments evaluated through NICE’s highly specialised technologies appraisal programme.
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	uin	278512
	answer	answer is ministerial correction date of answer 22/07/2019 answer text <p>The National Institute for Health and Care Excellence has advised that the highly specialised technologies (HST) programme has, to date, only needed to assess single products for single indications. Should a situation arise for the evaluation of multiple technologies for the same indication within the HST process, the feasibility and suitability of this would be considered at that point. Any such process would closely reflect the established multiple technology appraisal process, which is designed to appraise more than one technology.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 22/07/2019 15:38:13 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4244 label Biography information for Jonathan Ashworth